364 filings
Page 8 of 19
6-K
2b2w y8fko79
4 Dec 17
BioLineRx Reports Overall Survival Results from
12:00am
6-K
z8thr1h
21 Nov 17
Current report (foreign)
12:00am
6-K
m2pojpg9samnofd ioaa
20 Nov 17
BioLineRx Announces Partial Results of BL-8040
12:00am
6-K
xknuz
2 Nov 17
BioLineRx Announces Oral Presentation at ASH of Data
12:00am
6-K
tk2ekpe4gbelj
31 Oct 17
Current report (foreign)
12:00am
6-K
8ccmcuh7
18 Oct 17
BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040
12:00am
6-K
pha86t xv2ubphlv9k77
26 Sep 17
BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040
12:00am
6-K
77qmy0 pwwwp2rg08cde
21 Aug 17
BioLineRx Announces Regulatory Submission of Phase 3
12:00am
6-K
wtld7wz
15 Aug 17
Current report (foreign)
12:00am
6-K
1cm9njn 5gkh5eaxilgu
8 Aug 17
BioLineRx Reports Second Quarter 2017 Financial Results
12:00am
6-K
syzb74eljlkm 5e
31 Jul 17
Current report (foreign)
12:00am
6-K
y913nu
26 Jul 17
BioLineRx Announces Additional Investment
12:00am
6-K
uk3ga1nptp26 jd6h4
10 Jul 17
BioLineRx Announces Initiation of Phase 1b/2 Trial of
12:00am
6-K
al2wodw78nvio7ax
5 Jul 17
Current report (foreign)
12:00am
6-K
voatyxk9can
12 Jun 17
Current report (foreign)
12:00am
6-K
adxc2a
1 Jun 17
BioLineRx Reports Regulatory Submissions of Three
12:00am
6-K
cmoim fvk8
30 May 17
Current report (foreign)
12:00am
6-K
5f86p6m8a2q
25 May 17
BioLineRx Reports First Quarter 2017 Financial Results
12:00am
6-K
e72l5wenuzm24tv4
22 May 17
BioLineRx Announces Regulatory Submission for Phase 1b
12:00am
6-K
8fa3w f6uywt0k3xpd5
17 May 17
Current report (foreign)
12:00am